Blacksburg, VA-based Intrexon has garnered $25 million in its third round of venture capital. Much of that money has been earmarked to fund the company's pre-clinical work in gene-based therapies. CEO Robert Beech told reporters that the money would allow the company to triple in size by the end of the year, swelling its work force to about 130. Intrexon moved from Cincinnati in 2004 when it had only four employees. New River Management provided the new funding.
- here's the report from The Roanoke Times
ALSO: Hercules Technology Growth Capital is providing $10 million in venture debt financing to Neosil. Release